Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Abterra Biosciences
Abterra Biosciences is a biotechnology company specializing in next-generation antibody therapeutics development. They leverage advanced technologies including next-generation sequencing, mass…
Abterra Biosciences
Abterra Biosciences is a biotechnology company specializing in next-generation antibody therapeutics development. They leverage advanced technologies including next-generation sequencing, mass…
TL;DR
Headquarters: San Diego (Sorrento Valley), CA
Founded: 2009 (spin-out from UC San Diego)
Core offering: Antibody sequencing, immune‑repertoire analysis, and antibody discovery platforms
Key technologies: Next‑generation sequencing, mass spectrometry, machine learning
Notable products: Valens, Reptor, Alicanto, Griffin, Quorum
Company Overview
Problem Domain
Antibody discovery and sequencing for research institutions and biotech companies developing antibody therapeutics.
Founded
2009
Industry
Biotechnology
Tech Stack
Funding Track Record
Reported grant funding / SBIR support; company has participated in angel investor events (Seattle Angel Conference).
Investor Signal
“Received grant funding from the U.S. National Institutes of Health (SBIR); participated in angel investing events”